JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 6227.0
  • +260.0+4.36%
20min DelayTrading Aug 9 13:04 JST
10.46TMarket Cap31.48P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chugai Pharmaceutical Earnings Date

Currency: JPY

Period

Q2 FY2024 Earnings

Jul 25, 2024

Revenue(YoY)

315.91B

+18.13%
EPS(YoY)

67.97

+34.43%
Analyst Rating

Buy

Aug 8, 2024

Chugai Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 291.455B--
Oct 25, 20242024/Q3-- / 274.305B--
Jul 25, 20242024/Q2315.911B / 276.349B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 291.455B--
Oct 25, 20242024/Q3-- / 274.305B--
Jul 25, 20242024/Q2315.911B / 276.349B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--

Unlock Free Earnings Estimates

Chugai Pharmaceutical Earnings Reports

  • Chugai Pharmaceutical: Confirmatory letter.

    Jul 26 02:02 ET

  • Chugai Pharmaceutical: Interim report - 114th Period (01/01/2024 - 12/31/2024)

    Jul 26 02:01 ET

  • Chugai Pharmaceutical: Confirmation letter

    Jul 26 01:35 ET

  • Chugai Pharmaceutical: (Correction/Correction of numerical data) Correction of some parts of the "Fiscal Year ending December 2023 Consolidated Financial Statements [IFRS] (Consolidated)"

    Jul 26 01:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Buy

    • Strong Buy

      42.86%

    • Buy

      14.29%

    • Hold

      35.71%

    • Underperform

      7.14%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg